Overview
FTH market data
Price History
FTH price chart · 1M
- O
- 39.68
- H
- 41.02
- L
- 39.57
- C
- 40.27
- Vol
- 19,600.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $39.68
- Previous Close
- $39.43
- Day High
- $41.02
- Day Low
- $39.57
- 52 Week High
- $41.02
- 52 Week Low
- $10.91
- 7 Day Return
- +19.48%
- 30 Day Return
- +64.64%
- 90 Day Return
- +208.35%
- 1 Year Return
- +74.25%
- Daily Notional Volume
- $789.3K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$16.72 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.08 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $13.43 – $40.89 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1B.
Company News
10 captured
Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsightGlobenewswire Inc ·
This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For FridayBenzinga ·
Needham Initiates Coverage On Faeth Therapeutics with Buy Rating, Announces Price Target of $56Benzinga ·
8-K filing — Faeth Therapeutics, Inc. (FTH)SEC EDGAR ·